Featured Commentary


Daily Updates/ Market Daily Updates

Stock Market Today: November 18, 2019

11/18/2019 The futures market started positively, as an interest-rate cut in China buoyed the S&P 500 futures to an all-time high. The accommodative policy was seen as a positive by many traders. But by the time the stock market opened, this move higher was erased, as concerns about U.S. trade negotiations with China took hold. The Dow, S&P 500, and NASDAQ reached all-time highs during the session. Then, the composites tapered off in the final portion of trading and ended not too far off of breakeven levels. All told, the Dow closed higher by 31 points, the S&P 500 finished up two points, and the NASDAQ.
read more

Daily Updates/ Market Daily Updates

Stock Market Today: October 30, 2019

10/30/2019 Equities traded in a sideways range earlier today, but turned nicely higher after 2PM (EDT) following the Federal Reserve’s interest rate announcement. The central bank chose to cut interest rates by another 0.25%, making this the third reduction this year. However, the bank hinted that further easing may not be easily forthcoming. While Wall Street seemed pleased with the news, the market’s reaction was somewhat subdued at first.
read more

Highlights/ StockHighlights

Dow 30 Earnings: Pfizer Third Quarter 2019

10/29/2019 New York-based drugmaker and Dow-30 component Pfizer (PFE) reported third-quarter GAAP earnings of $1.36 a share, versus $0.69 in the comparable period of 2018. The sharp year-over-year improvement can be largely attributed to an $8.1 billion gain tied to the closing of the company's consumer health joint venture with GlaxoSmithKline. The comp received additional support from reductions in production and SI&A expenses, helping to offset a double-digit increase in R&D costs and lower revenues. Meantime, adjusted earnings, which exclude one-time gains, losses, and other nonrecurring items, and are more closely followed by Wall Street, came in at $0.75 a share, versus $0.77 in Q3, 2018.
read more

Daily Updates/ Market Daily Updates

Stock Market Today: July 30, 2019

07/30/2019 The marketsstarted out negatively today, as a few worrisome earnings reports from companies were released both yesterday and before the bell this morning. These chilled the market some. Additionally, concerns increased about U.S. trade negotiations with China, due to fears regarding the timing and even likelihood of an eventual deal. All told, the Dow closed down 23 points, the S&P 500 finished lower by eightpoints, and the NASDAQ fell 37 points.
read more

Highlights/ StockHighlights

Dow 30 Earnings: Pfizer Second Quarter 2019

07/29/2019 New York-based drugmaker and Dow-30 component Pfizer (PFE) reported second-quarter GAAP earnings of $0.89 a share, versus $0.65 in the comparable period of 2018. The year-over-year improvement was fueled primarily by reduced production costs (-12%) and lower taxes, which helped to offset a modest decline in total revenues. Meantime, adjusted earnings, which exclude one-time gains, losses, and other nonrecurring items, and are more closely followed by Wall Street, came in at $0.80 a share, versus $0.77 in Q2, 2018.
read more

Highlights/ StockHighlights

Dow 30 Earnings: Pfizer First Quarter 2019

04/30/2019 Drugmaker and Dow-30 component Pfizer reported better-than-anticipated March-period earnings. Investors,encouraged by the biopharma portfolio, bid the stock up slightly in early trading.
read more

Highlights/ StockHighlights

Dow 30 Earnings: Pfizer Fourth Quarter 2018

01/29/2019 New York-based drugmaker and Dow-30 component Pfizer (PFE) reported a fourth-quarter GAAP loss of $0.07 a share, versus earnings of $2.02 in the comparable period of 2017. While revenues inched up a few percentage points year to year (more below), a sharp increase in restructuring costs and significant asset impairment charges weighed heavily on the bottom-line tally. The comparison was further skewed by a massive tax benefit ($1.79 a share) realized in fourth quarter of 2017. Meantime, adjusted earnings, which exclude one-time gains, losses, and other nonrecurring items, and are more closely followed by Wall Street, came in at $0.64 a share, versus $0.62 last year.
read more

Highlights/ StockHighlights

Dow 30 Earnings: Pfizer Third Quarter 2018

10/30/2018 Drugmaker and Dow-30 component Pfizer reported mixed third-quarter results, and the stock headed lower.
read more

Highlights/ StockHighlights

Dow 30 Earnings: Pfizer Second Quarter 2018

07/31/2018 New York-based drugmaker and Dow-30 component Pfizer (PFE) reported second-quarter earnings of $0.65 a share, versus $0.51 in the comparable period of 2017. The year-over-year improvement was driven primarily by reduced taxes (-12%) and higher revenues (+4%), partially offset by increased costs tied to production (+10%) and SG&A (+3%).
read more

PAGE
OF 12